Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.
about
Identification of spirocyclic or phosphate substituted quinolizine derivatives as novel HIV-1 integrase inhibitors: a patent evaluation of WO2016094197A1, WO2016094198A1 and WO2016154527A1.What do docking and QSAR tell us about the design of HIV-1 reverse transcriptase nonnucleoside inhibitors?Discovery of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the Tolerant Region I of NNIBP.Further Exploring Solvent-Exposed Tolerant Regions of Allosteric Binding Pocket for Novel HIV-1 NNRTIs Discovery.Discovery of Novel Diarylpyrimidine Derivatives as Potent HIV-1 NNRTIs Targeting the "NNRTI Adjacent" Binding Site.Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.Structural basis for potent and broad inhibition of HIV-1 RT by thiophene[3,2-]pyrimidine non-nucleoside inhibitors
P2860
Q40106207-96CFCD07-8E14-4A80-92EE-14E6B9625476Q47136053-260EE52E-B6B2-45E1-B581-6D367D778359Q47575876-5AAF98FE-0ED5-4718-848A-0CB259E527C1Q52579066-B10BE28C-AE00-4722-96CC-A2295296CE42Q52579081-D433F5B0-C909-4C17-B76E-1B5F76D71415Q52596192-278622B4-DD08-4CEF-BD0A-6E1DE4354F38Q56531878-3F359AA7-5469-4B18-AFF6-280A52B73ADE
P2860
Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Structure-Based Optimization o ...... esistance-Associated Variants.
@en
type
label
Structure-Based Optimization o ...... esistance-Associated Variants.
@en
prefLabel
Structure-Based Optimization o ...... esistance-Associated Variants.
@en
P2093
P50
P1476
Structure-Based Optimization o ...... esistance-Associated Variants.
@en
P2093
Dongwei Kang
Gaochan Wu
Heng Zhang
Zengjun Fang
P304
P356
10.1021/ACS.JMEDCHEM.7B00332
P407
P577
2017-05-08T00:00:00Z